Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7972)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2024 (publication date) through Mar 13, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Michalczuk MT, Longo L, Keingeski MB, Basso BS, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CP, Uribe-Cruz C, Cerski CTS, Filippi-Chiela E, Álvares-da-Silva MR. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World J Hepatol 2024; 16(1): 75-90 [PMID: 38313241 DOI: 10.4254/wjh.v16.i1.75] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Michalczuk MT, Longo L, Keingeski MB, Basso BS, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CP, Uribe-Cruz C, Cerski CTS, Filippi-Chiela E, Álvares-da-Silva MR. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World J Hepatol 2024; 16(1): 75-90 [PMID: 38313241 DOI: 10.4254/wjh.v16.i1.75] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i1/75.htm |
| Number | Citing Articles |
| 1 |
Felipe Schütz, Larisse Longo, Melina Belén Keingeski, Eduardo Filippi-Chiela, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva. Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model. World Journal of Hepatology 2024; 16(12): 1468-1479 doi: 10.4254/wjh.v16.i12.1468
Abstract(509) |
Core Tip(471) |
Full Article(HTML)(1720)
|
Full Article with Cover (PDF)-1459K(248)
|
Audio-846K(10)
|
Peer-Review Report-178K(85)
|
Answering Reviewers-115K(88)
|
Supplementary Material-145K(86)
|
Full Article (PDF)-1260K(158)
|
Full Article (XML)-168K(97)
|
Times Cited (4)
|
Total Visits (5983)
|
Open
|
| 2 |
Ling Zhao, Chunlan Zou, Junxian Li, Yang Yang, Yuanyuan Han, Tingyu Ke. Molecular mechanism of ischemic postconditioning in promoting diabetic ischemic brain injury repair via the microRNA‐34a–BDNF–SIX3 signaling axis. Animal Models and Experimental Medicine 2026; doi: 10.1002/ame2.70158
|
| 3 |
Larisse Longo, Gabriel Guerreiro, Luiza Behrens, Matheus Pereira, Carlos Pinzon, Carlos Cerski, Carolina Uribe‑Cruz, Mário Álvares‑da‑Silva. Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model. Biomedical Reports 2024; 22(1) doi: 10.3892/br.2024.1882
|
| 4 |
Xinlei Ma, Wei Zheng, Chensi Wu, Chengan Xu, Xin Ji, Keyang Xu, Qiaoqiao Yin. Roles of Extracellular Vesicle-Derived microRNAs in Metabolic Dysfunction-Associated Steatotic Liver Disease to Hepatocellular Carcinoma. Biomedicines 2026; 14(3): 528 doi: 10.3390/biomedicines14030528
|